These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1354750)

  • 1. N-(5,5-diacetoxypent-1-yl)doxorubicin: a new intensely potent doxorubicin analogue.
    Cherif A; Farquhar D
    J Med Chem; 1992 Aug; 35(17):3208-14. PubMed ID: 1354750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensely potent doxorubicin analogues: structure-activity relationship.
    Farquhar D; Cherif A; Bakina E; Nelson JA
    J Med Chem; 1998 Mar; 41(6):965-72. PubMed ID: 9526570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor evaluation of bis[(pivaloyloxy)methyl] 2'-deoxy-5-fluorouridine 5'-monophosphate (FdUMP): a strategy to introduce nucleotides into cells.
    Farquhar D; Khan S; Srivastva DN; Saunders PP
    J Med Chem; 1994 Nov; 37(23):3902-9. PubMed ID: 7966151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
    Wang YQ; Farquhar D
    J Med Chem; 1991 Jan; 34(1):197-203. PubMed ID: 1992116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells.
    McClean S; Hosking LK; Hill BT
    J Natl Cancer Inst; 1993 Jan; 85(1):48-53. PubMed ID: 8093217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of doxorubicin resistance by tetrandrine in Chinese hamster ovary cell line.
    He QY; Jiang B; Zhang HQ; Xue SB
    Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):416-9. PubMed ID: 1300043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lack of adriamycin (ADR) resistance in Chinese hamster ovary (CHO) cells overexpressing P-glycoprotein (Pgp) following in vitro exposure to fractionated X-irradiation.
    Whelan RD; Hosking LK; Hill BT
    Biochem Soc Trans; 1991 Apr; 19(2):125S. PubMed ID: 1679723
    [No Abstract]   [Full Text] [Related]  

  • 8. Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells.
    Turner RN; Curtin NJ
    Br J Cancer; 1996 Apr; 73(7):856-60. PubMed ID: 8611395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug resistance of doxorubicin-resistant CHO cell line].
    Jiang B; Zhang HQ; Xue SB
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):189-92. PubMed ID: 7516612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
    Florent JC; Dong X; Gaudel G; Mitaku S; Monneret C; Gesson JP; Jacquesy JC; Mondon M; Renoux B; Andrianomenjanahary S; Michel S; Koch M; Tillequin F; Gerken M; Czech J; Straub R; Bosslet K
    J Med Chem; 1998 Sep; 41(19):3572-81. PubMed ID: 9733483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique interaction between polyamine and multidrug resistance (P-glycoprotein) transporters in cultured Chinese hamster ovary cells transfected with mouse mdr-1 gene.
    Aziz SM; Worthen DR; Yatin M; Ain KB; Crooks PA
    Biochem Pharmacol; 1998 Jul; 56(2):181-7. PubMed ID: 9698071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines.
    Huet S; Schott B; Robert J
    Br J Cancer; 1992 Apr; 65(4):538-44. PubMed ID: 1348623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100).
    Sognier MA; Zhang Y; Eberle RL; Sweet KM; Altenberg GA; Belli JA
    Biochem Pharmacol; 1994 Jul; 48(2):391-401. PubMed ID: 7914406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of multidrug resistance in Chinese hamster ovary cells by the immunosuppressive agent rapamycin.
    Hoof T; Demmer A; Christians U; Tümmler B
    Eur J Pharmacol; 1993 Jun; 246(1):53-8. PubMed ID: 7689059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
    Takeda Y; Nishio K; Sugimoto Y; Kasahara K; Kubo S; Fujiwara Y; Niitani H; Saijo N
    Int J Cancer; 1991 Jul; 48(6):931-7. PubMed ID: 1677641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4'-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells.
    Borrel MN; Pereira E; Fiallo M; Garnier-Suillerot A
    Eur J Biochem; 1994 Jul; 223(1):125-33. PubMed ID: 7518390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study.
    Aroui S; Brahim S; Waard MD; Kenani A
    Biochem Biophys Res Commun; 2010 Jan; 391(1):419-25. PubMed ID: 19914216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonaqueous biocatalytic synthesis of new cytotoxic doxorubicin derivatives: exploiting unexpected differences in the regioselectivity of salt-activated and solubilized subtilisin.
    Altreuter DH; Dordick JS; Clark DS
    J Am Chem Soc; 2002 Mar; 124(9):1871-6. PubMed ID: 11866597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensely potent morpholinyl anthracyclines.
    Acton EM; Tong GL; Mosher CW; Wolgemuth RL
    J Med Chem; 1984 May; 27(5):638-45. PubMed ID: 6716401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.